Pharma Industry News

Novartis investors demand action amid ‘swamp’ of bribery allegations in Greece

Written by David Miller

Novartis investors want the company to tighten up. At the company’s Friday annual meeting—barely a week after Greek lawmakers officially opened a bribery investigation—shareholders said top brass needs to be more vigilant. “Corruption cannot be allowed to become a tradition,” one shareholder said.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]